For investors, by investors
Results 1 - 10 of 50 : 1 2 3 4 5 Next
Make Money in Growing Small Caps -- the Easy Way
Why resort to guessing which companies will perform best?
Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings
Don't just count the cash, time it.
Should You Get Out of BioMarin Pharmaceutical Before Next Quarter?
Look here for a clue.
The 8 Highest Potential Returns in Biotechnology
What the numbers tell us.
It's going to need it.
Roundtable: The World's Best Biotechs
Fools chime in on the best in the biotech space.
Will Benlysta Get Past the FDA?
That might not even be the right question.
Rare Diseases, Big Opportunity
"Orphan" drugs to keep your eye on.
7 Reasons to Worry About Next Week
7 Reasons to Worry About Next Week
BioMarin Pharmaceutical Passes This Key Test
Look here for a clue.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK